Sustainable fat loss requires medical insight, modern medications, and personalized coaching — not just willpower. Our bilingual primary care team combines GLP-1 therapy, nutrition counseling, and metabolic monitoring for lasting results.
Schedule Your ConsultationObesity is now recognized as a chronic, complex, and treatable medical disease — not a personal failing. Modern obesity medicine combines proven behavioral coaching with prescription therapies that finally make sustained weight loss achievable for the majority of patients.
According to the CDC, more than 40% of U.S. adults have obesity, and millions more have metabolic syndrome — a cluster of insulin resistance, central obesity, hypertension, and dyslipidemia that dramatically increases cardiovascular and diabetes risk.
Our clinical fat-loss program addresses both conditions together. We don't just track the scale — we measure waist circumference, lipids, A1c, blood pressure, and body composition to ensure your weight loss actually improves your metabolic health.
🎬 Video Coming Soon: Dr. Teresa Moreno on GLP-1 medications and metabolic health.
Metabolic syndrome is diagnosed when 3 or more of the following are present:
Waist circumference greater than 40 inches (men) or 35 inches (women).
Triglycerides ≥150 mg/dL or on medication for high triglycerides.
HDL less than 40 mg/dL (men) or less than 50 mg/dL (women).
BP ≥130/85 or on antihypertensive medication.
Fasting glucose ≥100 mg/dL or on diabetes medication.
The underlying driver — often improves dramatically with 5–10% weight loss alone.
BMI, waist circumference, body composition, lipid panel, A1c, fasting insulin, liver function, thyroid, vitamin D, and B12 — through our in-office lab services.
FDA-approved options like Wegovy (semaglutide), Zepbound (tirzepatide), Ozempic, and Mounjaro reduce appetite, slow gastric emptying, and produce 15–22% body weight loss over 12–18 months. We handle prior authorization and dose titration.
Mediterranean-style or low-carb plans tailored to your culture and preferences. Bilingual coaching in Spanish and English. Practical, sustainable changes — not extreme dieting.
Joint management of blood pressure, cholesterol, and pre-diabetes / diabetes — because metabolic syndrome is fundamentally a cardiovascular disease.
Through chronic care management, monthly check-ins, and dose maintenance to prevent regain after initial weight loss.
Many patients on GLP-1 therapy benefit from B12 injections to maintain energy during caloric reduction.
3+ of: large waist, high triglycerides, low HDL, high BP, elevated fasting glucose. It dramatically raises diabetes and heart disease risk.
Yes — when prescribed and monitored medically. Side effects are usually mild GI symptoms that improve over time.
Clinical programs with GLP-1 + lifestyle: 15–22% over 12–18 months. Lifestyle alone: 5–10%.
Coverage varies. Diabetes-indicated GLP-1s are widely covered. Pure weight-loss approvals vary — we help navigate prior authorizations.
Most patients regain weight without ongoing treatment. Obesity is a chronic disease — long-term maintenance is part of the plan.
Book a consultation to design a personalized program.
Call (305) 676-8217